253 related articles for article (PubMed ID: 34826792)
1. Integrated Positron Emission Tomography/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer's disease.
Gao F
Eur J Radiol; 2021 Dec; 145():110017. PubMed ID: 34826792
[TBL] [Abstract][Full Text] [Related]
2. Imaging Methods Applicable in the Diagnostics of Alzheimer's Disease, Considering the Involvement of Insulin Resistance.
Hnilicova P; Kantorova E; Sutovsky S; Grofik M; Zelenak K; Kurca E; Zilka N; Parvanovova P; Kolisek M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834741
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
[TBL] [Abstract][Full Text] [Related]
4. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
5. Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.
Raji CA; Torosyan N; Silverman DHS
J Alzheimers Dis; 2020; 77(3):935-947. PubMed ID: 32804147
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.
Del Sole A; Malaspina S; Magenta Biasina A
Funct Neurol; 2016; 31(4):205-215. PubMed ID: 28072381
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and acceptance of simultaneous amyloid PET/MRI.
Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
Musiek ES; Chen Y; Korczykowski M; Saboury B; Martinez PM; Reddin JS; Alavi A; Kimberg DY; Wolk DA; Julin P; Newberg AB; Arnold SE; Detre JA
Alzheimers Dement; 2012 Jan; 8(1):51-9. PubMed ID: 22018493
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.
Soni N; Ora M; Bathla G; Nagaraj C; Boles Ponto LL; Graham MM; Saini J; Menda Y
Neuroradiol J; 2021 Aug; 34(4):263-288. PubMed ID: 33666110
[TBL] [Abstract][Full Text] [Related]
10. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
[TBL] [Abstract][Full Text] [Related]
12. Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer's Disease Diagnosis.
Liu M; Cheng D; Wang K; Wang Y;
Neuroinformatics; 2018 Oct; 16(3-4):295-308. PubMed ID: 29572601
[TBL] [Abstract][Full Text] [Related]
13. The use of positron emission tomography/magnetic resonance imaging in dementia: A literature review.
Lorking N; Murray AD; O'Brien JT
Int J Geriatr Psychiatry; 2021 Oct; 36(10):1501-1513. PubMed ID: 34490651
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks.
Abdelaziz M; Wang T; Elazab A
J Biomed Inform; 2021 Sep; 121():103863. PubMed ID: 34229061
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of 11C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease.
Kitajima K; Abe K; Takeda M; Yoshikawa H; Ohigashi M; Osugi K; Koyama H; Yamakado K
Medicine (Baltimore); 2021 Jan; 100(3):e23969. PubMed ID: 33545981
[TBL] [Abstract][Full Text] [Related]
16. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.
Kapoor A; Bartha R; Black SE; Borrie M; Freedman M; Gao F; Herrmann N; Mandzia J; Ozzoude M; Ramirez J; Scott CJM; Symons S; Fischer CE; Frank A; Seitz D; Wolf MU; Verhoeff NPLG; Naglie G; Reichman W; Masellis M; Mitchell SB; Tang-Wai DF; Tartaglia MC; Kumar S; Pollock BG; Rajji TK; Finger E; Pasternak SH; ; Swartz RH
J Alzheimers Dis; 2020; 74(3):747-757. PubMed ID: 32116253
[TBL] [Abstract][Full Text] [Related]
17. Hybrid Imaging of Vascular Cognitive Impairment.
Frantellizzi V; Conte M; De Vincentis G
Semin Nucl Med; 2021 May; 51(3):286-295. PubMed ID: 33353723
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging modality fusion in Alzheimer's classification using convolutional neural networks.
Punjabi A; Martersteck A; Wang Y; Parrish TB; Katsaggelos AK;
PLoS One; 2019; 14(12):e0225759. PubMed ID: 31805160
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
[TBL] [Abstract][Full Text] [Related]
20. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
Atri A
Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
